Imagion Biosystems Limited (IBXXF)
USD 0.01
(-58.33%)
USD 0.01
(-58.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.31 Million | -8.07 Million | -5.06 Million | -4.62 Million | -4.18 Million | -6.56 Million |
| Net Income | -13.06 Million | -9.8 Million | -6.02 Million | -5.36 Million | -3.43 Million | -8.34 Million |
| Depreciation & Amortization | 1.18 Million | 1.1 Million | 404.43 Thousand | 360.57 Thousand | 142.23 Thousand | 213.79 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 462.71 Thousand | 653.05 Thousand | 497.53 Thousand | 423.57 Thousand | -1.05 Million | 837.13 Thousand |
| Change in working capital | 370.74 Thousand | -197.67 Thousand | -34.13 Thousand | -66 Thousand | -7391.00 | 246.55 Thousand |
| Other non-cash items | 3.1 Million | 169.42 Thousand | 88.37 Thousand | 22.77 Thousand | 173.58 Thousand | 475.32 Thousand |
| Investing Cash Flow | -190.37 Thousand | -468.72 Thousand | -310.09 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Investments in PPE | -190.37 Thousand | -507.31 Thousand | -218.83 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 38.58 Thousand | -91.26 Thousand | - | - | - |
| Financing Cash Flow | 4.29 Million | -962.06 Thousand | 5.14 Million | 14.52 Million | 3.32 Million | 4.1 Million |
| Debt repayment | -3.5 Million | -964.82 Thousand | -359.25 Thousand | -233.81 Thousand | -35.39 Thousand | -128.49 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -6109.00 | -1.34 Million | -13.3 Thousand | -54.18 Thousand |
| Common Stock Issuance | 2.38 Million | 2759.00 | 5.51 Million | 16.1 Million | 3.37 Million | 4.28 Million |
| Other Financing Activities | -1.59 Million | -964.82 Thousand | -359.25 Thousand | -246.8 Thousand | -35.39 Thousand | -128.49 Thousand |
| Accounts receivables | 370.74 Thousand | -197.67 Thousand | -34.13 Thousand | -66 Thousand | -20.9 Thousand | -44.58 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | 13.5 Thousand | 291.13 Thousand |
| Cash at beginning of period | 4.44 Million | 13.39 Million | 13.2 Million | 3.4 Million | 4.36 Million | 6.87 Million |
| Cash at end of period | 227.08 Thousand | 4.44 Million | 13.39 Million | 13.2 Million | 3.4 Million | 4.36 Million |
| Capital Expenditure | -190.37 Thousand | -507.31 Thousand | -218.83 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Effect of forex changes on cash | -4236.00 | 557.33 Thousand | 425.76 Thousand | -90.95 Thousand | -96.7 Thousand | 41.84 Thousand |
| Net cash flow / Change in cash | -4.21 Million | -8.94 Million | 193.22 Thousand | 9.79 Million | -965.38 Thousand | -2.5 Million |
| Free Cash Flow | -8.5 Million | -8.58 Million | -5.28 Million | -4.63 Million | -4.19 Million | -6.65 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.06 Million | -2.39 Million | -2.39 Million | -3.84 Million | -3.84 Million | -9.8 Million |
| Depreciation & Amortization | 1.18 Million | 299.38 Thousand | 299.38 Thousand | 292.24 Thousand | 292.24 Thousand | 1.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 462.71 Thousand | 108.69 Thousand | 108.69 Thousand | 122.66 Thousand | 122.66 Thousand | 653.05 Thousand |
| Change in working capital | 370.74 Thousand | 185.37 Thousand | 185.37 Thousand | - | - | -197.67 Thousand |
| Other non-cash items | 3.1 Million | 653.77 Thousand | 653.77 Thousand | 416.84 Thousand | 416.84 Thousand | 169.42 Thousand |
| Investing Cash Flow | -190.37 Thousand | -83.42 Thousand | -83.42 Thousand | -11.76 Thousand | -11.76 Thousand | -468.72 Thousand |
| Investments in PPE | -190.37 Thousand | -83.42 Thousand | -83.42 Thousand | -11.76 Thousand | -11.76 Thousand | -507.31 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 38.58 Thousand |
| Financing Cash Flow | 4.29 Million | 1.13 Million | 1.13 Million | 1.01 Million | 1.01 Million | -962.06 Thousand |
| Debt repayment | -3.5 Million | - | - | - | - | -964.82 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.38 Million | - | - | - | - | 2759.00 |
| Other Financing Activities | -1.59 Million | 1.13 Million | 1.13 Million | 1.01 Million | 1.01 Million | -964.82 Thousand |
| Accounts receivables | 370.74 Thousand | 185.37 Thousand | 185.37 Thousand | - | - | -197.67 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 4.44 Million | - | - | - | - | 13.39 Million |
| Cash at end of period | 227.08 Thousand | -113.23 Thousand | -113.23 Thousand | -1.99 Million | -1.99 Million | 4.44 Million |
| Capital Expenditure | -190.37 Thousand | -83.42 Thousand | -83.42 Thousand | -11.76 Thousand | -11.76 Thousand | -507.31 Thousand |
| Effect of forex changes on cash | -4236.00 | -16.38 Thousand | -16.38 Thousand | 14.27 Thousand | 14.27 Thousand | 557.33 Thousand |
| Net cash flow / Change in cash | -4.21 Million | -113.23 Thousand | -113.23 Thousand | -1.99 Million | -1.99 Million | -8.94 Million |
| Free Cash Flow | -8.5 Million | -1.23 Million | -1.23 Million | -3.02 Million | -3.02 Million | -8.58 Million |
4492
6149
300176
TRZBF
LGO
2281